Propeller’s research team recently shared new data insights into the value of connected digital technology at the virtual AAAAI Annual Meeting. One abstract presented with leading allergists and pulmonologists at Children’s Hospital Colorado has confirmed what we’ve long suspected about our digital health platform: Patients are more adherent to their asthma medication regimen when they connect both their controller and rescue inhalers to Propeller. In the study of 5,105 patients with asthma, patients using Propeller for controller and rescue usage monitoring had nearly 5% higher absolute medication adherence than those who used Propeller to track their controller medication alone. Improvements in adherence were highest in patients with very poor control* of their asthma — often the patients who stand to benefit the most from a platform like Propeller.
The American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting couldn’t take place this year due to the novel coronavirus (COVID-19) pandemic. However, there’s still a wealth of newly published research posters from the conference available online. Propeller contributed to six posters with research partners at Northshore University Health System, Children’s Hospital Colorado and Northwestern University Feinberg School of Medicine. Research into the clinical effectiveness of the remote monitoring of respiratory medication usage is particularly important at a time when patients at higher risk of COVID-19 complications have decreased access to in-person care. Here’s a snapshot of each poster. Click the links to read each publication in full.